other advisors, solicitors, printing, advertising, postage, transportation, litigation, and other costs incidental to the solicitation. Monarch anticipates that the total expenses that they will incur in furtherance of, or in connection with, the solicitation of proxies for the 2018 Annual Meeting will be approximately $[1,000,000]. The actual amount could be higher or lower depending on the facts and circumstances arising in connection with any such solicitation. As of the date hereof, Monarch has incurred approximately $[ ] of solicitation expenses.
CERTAIN INFORMATION REGARDING THE PARTICIPANTS
Annex A hereto includes information pertaining to the participants in this solicitation, including, as applicable, the name, present principal occupation or employment, business address, and certain other information with respect to such participants.
Information as to any substantial interest, direct or indirect, by security holdings or otherwise of the participants in this solicitation with respect to the Nomination Proposal or the approval of the Stockholder Proposal is set forth herein. Except as otherwise set forth herein and in Annex A, which is incorporated herein by reference, none of the participants in this solicitation beneficially owns any securities of the Company or has any personal ownership interest, direct or indirect, in any securities of the Company.
During the past ten years, no participant in this solicitation has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
The Company has disclosed that as of October 31, 2017, there were 22,503,907 shares of Common Stock outstanding according to the Company’s Form 10-Q filed by the Company with the SEC on November 6, 2017. The Company’s proxy statement for the 2018 Annual Meeting (when available) will provide the current number of shares of Common Stock outstanding and entitled to vote at the 2018 Annual Meeting. Each share of Common Stock is entitled to one vote on all matters presented at the 2018 Annual Meeting.
The date of purchase and number of shares of Common Stock purchased are set forth in Annex A to this proxy statement. Set forth in Annex A hereto are transactions in the Company’s securities effected by the participants in this solicitation within the past two years. Other than as disclosed in Annex A, no participant in this solicitation has effected any transaction in securities of the Company in the past two years.
As of the date hereof, each of the Nominees does not own beneficially or of record any securities of the Company and has not entered into any transactions in securities of the Company during the past two years.
As of the date hereof, each of the Nominees does not own beneficially any derivative instruments or any other direct or indirect opportunity to profit or share in any profit derived from any increase or decrease in the value of shares of the Company, and has not entered into any transactions in Derivative Instruments (as defined in the Bylaws) or any other direct or indirect opportunity to profit or share in any profit derived from any increase or decrease in the value of shares of the Company during the past two years.
Other than as set forth in this proxy statement or in Annex A hereto, after reasonable inquiry, no participant in this solicitation, nor any of their respective associates or majority-owned subsidiaries, is, or has been within the past year, a party to any contract, arrangement or understanding with any person with respect to any securities of the Company including, but not limited to, joint ventures, loan or option arrangements, puts or calls, guarantees against loss or guarantees of profit, division of losses or profit, or the giving or withholding of proxies.
Other than as set forth in this proxy statement or in Annex A hereto, after reasonable inquiry, no participant in this solicitation, and no associate of any participant in this solicitation, owns beneficially, directly or indirectly, or of record but not beneficially, any securities of the Company, or any parent or subsidiary of the Company.
19